Barclays’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-69,772
| Closed | -$29K | – | 7655 |
|
|
2018
Q4 | $29K | Buy |
69,772
+69,714
| +120,197% | +$43.3K | ﹤0.01% | 5747 |
|
|
2018
Q3 | $0 | Hold |
58
| – | – | ﹤0.01% | 7690 |
|
|
2018
Q2 | $0 | Sell |
58
-3
| -5% | -$7 | ﹤0.01% | 7625 |
|
|
2018
Q1 | $0 | Buy |
61
+3
| +5% | +$8 | ﹤0.01% | 7644 |
|
|
2017
Q4 | $0 | Hold |
58
| – | – | ﹤0.01% | 7367 |
|
|
2017
Q3 | $0 | Hold |
58
| – | – | ﹤0.01% | 7313 |
|
|
2017
Q2 | $0 | Hold |
58
| – | – | ﹤0.01% | 7263 |
|
|
2017
Q1 | $0 | Hold |
58
| – | – | ﹤0.01% | 7250 |
|
|
2016
Q4 | $0 | Hold |
58
| – | – | ﹤0.01% | 7099 |
|
|
2016
Q3 | $0 | Sell |
58
-486
| -89% | -$3K | ﹤0.01% | 6996 |
|
|
2016
Q2 | $2K | Buy |
544
+36
| +7% | +$235 | ﹤0.01% | 6037 |
|
|
2016
Q1 | $6K | Buy |
508
+450
| +776% | +$8.94K | ﹤0.01% | 5649 |
|
|
2015
Q4 | $1K | Sell |
58
-2,195
| -97% | -$66.4K | ﹤0.01% | 5909 |
|
|
2015
Q3 | $68K | Buy |
2,253
+1,225
| +119% | +$58.6K | ﹤0.01% | 4847 |
|
|
2015
Q2 | $51K | Buy |
1,028
+889
| +640% | +$62.7K | ﹤0.01% | 5130 |
|
|
2015
Q1 | $14K | Sell |
139
-892
| -87% | -$85K | ﹤0.01% | 6065 |
|
|
2014
Q4 | $92K | Buy |
1,031
+217
| +27% | +$20.7K | ﹤0.01% | 5278 |
|
|
2014
Q3 | $56K | Buy |
814
+752
| +1,213% | +$59.2K | ﹤0.01% | 5796 |
|
|
2014
Q2 | $5K | Sell |
62
-6
| -9% | -$368 | ﹤0.01% | 7151 |
|
|
2014
Q1 | $3K | Buy |
68
+29
| +74% | +$957 | ﹤0.01% | 7368 |
|
|
2013
Q4 | $1K | Buy |
39
+21
| +117% | +$500 | ﹤0.01% | 7484 |
|
|
2013
Q3 | $0 | Sell |
18
-5
| -22% | -$161 | ﹤0.01% | 7782 |
|
|
2013
Q2 | $1K | Buy |
+23
| New | +$862 | ﹤0.01% | 7631 |
|
Barclays's PTX Position: Q1 2019 in Review
Barclays sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2019, closing a stake of 69,772 shares — an estimated $29K sold.
Barclays first reported a position in PTX in Q2 2013 and held it in 23 quarters. The position peaked at $92K in Q4 2014. 1 fund tracked by Wall St. Rank holds PTX as of Q1 2019.
- Barclays reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2019 after selling out during the quarter.
- Barclays sold 69,772 Pernix Therapeutics Holdings, Inc. shares in Q1 2019, an estimated $29K.
- Barclays first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 23 quarters.
- Barclays's Pernix Therapeutics Holdings, Inc. position peaked at $92K in Q4 2014.
- 1 fund tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2019.
Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.